Literature DB >> 23039287

Believing is seeing: stroke thrombolysis remains unproven after the third International Stroke Trial (IST-3).

Daniel M Fatovich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23039287     DOI： 10.1111/j.1742-6723.2012.01605.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN： 1742-6723            Impact factor:   2.151


× No keyword cloud information.
  3 in total

1.  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

Authors:  Giorgio Costantino; Gian Marco Podda; Mattia Bonzi; Rodolfo Sbrojavacca
Journal:  Intern Emerg Med       Date:  2013-08-23       Impact factor: 3.397

Review 2.  Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Gyanendra Kumar; Drew Uhrig; Susan Fowler; Matthew C DeLaney; Andrei V Alexandrov
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 3.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.